Legal & General Group’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $816K | Sell |
82,056
-27,152
| -25% | -$243K | ﹤0.01% | 2205 |
|
|
2025
Q4 | $924K | Sell |
109,208
-3,108
| -3% | -$22.2K | ﹤0.01% | 2240 |
|
|
2025
Q3 | $586K | Hold |
112,316
| – | – | ﹤0.01% | 2397 |
|
|
2025
Q2 | $389K | Sell |
112,316
-16,899
| -13% | -$50.3K | ﹤0.01% | 2514 |
|
|
2025
Q1 | $339K | Buy |
129,215
+4,329
| +3% | +$17K | ﹤0.01% | 2517 |
|
|
2024
Q4 | $515K | Buy |
124,886
+1,589
| +1% | +$8.65K | ﹤0.01% | 2446 |
|
|
2024
Q3 | $873K | Buy |
123,297
+35,491
| +40% | +$265K | ﹤0.01% | 2283 |
|
|
2024
Q2 | $572K | Buy |
87,806
+719
| +0.8% | +$4.91K | ﹤0.01% | 2373 |
|
|
2024
Q1 | $723K | Buy |
87,087
+11,288
| +15% | +$110K | ﹤0.01% | 2299 |
|
|
2023
Q4 | $835K | Hold |
75,799
| – | – | ﹤0.01% | 2260 |
|
|
2023
Q3 | $637K | Sell |
75,799
-849
| -1% | -$9.13K | ﹤0.01% | 2338 |
|
|
2023
Q2 | $963K | Buy |
76,648
+1,588
| +2% | +$19.8K | ﹤0.01% | 2239 |
|
|
2023
Q1 | $1.24M | Buy |
75,060
+12,726
| +20% | +$228K | ﹤0.01% | 2081 |
|
|
2022
Q4 | $931K | Sell |
62,334
-883
| -1% | -$16.9K | ﹤0.01% | 2169 |
|
|
2022
Q3 | $1.41M | Buy |
63,217
+2,640
| +4% | +$57.9K | ﹤0.01% | 2023 |
|
|
2022
Q2 | $1.01M | Buy |
60,577
+9,527
| +19% | +$204K | ﹤0.01% | 2154 |
|
|
2022
Q1 | $1.53M | Buy |
51,050
+386
| +0.8% | +$9.37K | ﹤0.01% | 2092 |
|
|
2021
Q4 | $1.56M | Buy |
50,664
+11,121
| +28% | +$351K | ﹤0.01% | 2119 |
|
|
2021
Q3 | $1.25M | Buy |
39,543
+6,322
| +19% | +$213K | ﹤0.01% | 2180 |
|
|
2021
Q2 | $1.22M | Buy |
33,221
+7,393
| +29% | +$244K | ﹤0.01% | 2159 |
|
|
2021
Q1 | $893K | Buy |
25,828
+12,157
| +89% | +$528K | ﹤0.01% | 2215 |
|
|
2020
Q4 | $568K | Sell |
13,671
-23,461
| -63% | -$1.06M | ﹤0.01% | 2233 |
|
|
2020
Q3 | $1.58M | Buy |
+37,132
| New | +$1.42M | ﹤0.01% | 1865 |
|
Other funds holding RLAY
SIAU
CC
CC
PA
BG
VCM
NI
TCM